|
Peginterferon alfa-2a
Product Approval Information - Licensing Action
Proper name: Peginterferon alfa-2a
Tradename: PEGASYS
Manufacturer: Hoffman-La Roche, Inc, Nutley, NJ, License #0136
Indication for Use: Combination therapy with Ribavirin, USP (Copegus), for the treatment of chronic hepatitis C virus infection
Approval Date: 12/3/2002
Type of submission: Biologics license application supplement
Approval Letter
(Text)
Label
(PDF)
(Text)
Last Updated: 12/31/2002
Back
to Top
Back to Index
Updated: September 25, 2003 |
|